Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Abemaciclib on Metformin and Iohexol PK
NCT02884089Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of abemaciclib in breast cancer, sponsored by Eli Lilly and Company. Started Aug 2016; status: completed.
02
Drugs
abemaciclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02884089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02884089.